Catalyst Pharmaceuticals Inc (CPRX)
15.18
+0.14
(+0.90%)
USD |
NASDAQ |
May 01, 16:00
15.18
0.00 (0.00%)
After-Hours: 20:00
Catalyst Pharmaceuticals Accounts Payable (Quarterly): 14.80M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 14.80M |
September 30, 2023 | 4.598M |
June 30, 2023 | 4.421M |
March 31, 2023 | 3.391M |
December 31, 2022 | 3.975M |
September 30, 2022 | 2.529M |
June 30, 2022 | 2.315M |
March 31, 2022 | 5.139M |
December 31, 2021 | 2.768M |
September 30, 2021 | 2.752M |
June 30, 2021 | 2.924M |
March 31, 2021 | 2.561M |
December 31, 2020 | 4.256M |
September 30, 2020 | 2.005M |
June 30, 2020 | 5.805M |
March 31, 2020 | 1.348M |
December 31, 2019 | 4.117M |
September 30, 2019 | 4.147M |
June 30, 2019 | 3.329M |
March 31, 2019 | 2.940M |
December 31, 2018 | 2.337M |
September 30, 2018 | 1.341M |
June 30, 2018 | 0.9226M |
March 31, 2018 | 0.805M |
December 31, 2017 | 1.946M |
Date | Value |
---|---|
September 30, 2017 | 1.082M |
June 30, 2017 | 0.6923M |
March 31, 2017 | 0.9179M |
December 31, 2016 | 0.9332M |
September 30, 2016 | 1.055M |
June 30, 2016 | 0.7073M |
March 31, 2016 | 1.252M |
December 31, 2015 | 1.794M |
September 30, 2015 | 0.817M |
June 30, 2015 | 1.316M |
March 31, 2015 | 1.050M |
December 31, 2014 | 1.814M |
September 30, 2014 | 0.5248M |
June 30, 2014 | 1.238M |
March 31, 2014 | 0.9321M |
December 31, 2013 | 0.8508M |
September 30, 2013 | 1.473M |
June 30, 2013 | 0.4483M |
March 31, 2013 | 0.5672M |
December 31, 2012 | 1.366M |
September 30, 2012 | 0.3559M |
June 30, 2012 | 0.223M |
March 31, 2012 | 0.3503M |
December 31, 2011 | 0.2639M |
September 30, 2011 | 0.174M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.348M
Minimum
Mar 2020
14.80M
Maximum
Dec 2023
4.062M
Average
3.391M
Median
Mar 2023
Accounts Payable (Quarterly) Benchmarks
Pfizer Inc | 6.71B |
Sarepta Therapeutics Inc | 164.92M |
PTC Therapeutics Inc | 27.46M |
Corcept Therapeutics Inc | 17.40M |
Cytokinetics Inc | 21.51M |